血清内皮细胞黏附分子在 COVID-19 患者中的高表达。
Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
机构信息
Department of Infectious Diseases, Hunan Provincial People's Hospital (The First-affiliated Hospital of Hunan Normal University), Changsha, Hunan, China.
Institute of Emergency Medicine, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Hunan Provincial People's Hospital (The First-affiliated Hospital of Hunan Normal University), Changsha, Hunan, China.
出版信息
J Infect Dis. 2020 Aug 17;222(6):894-898. doi: 10.1093/infdis/jiaa349.
Abstract
In a retrospective study of 39 COVID-19 patients and 32 control participants in China, we collected clinical data and examined the expression of endothelial cell adhesion molecules by enzyme-linked immunosorbent assays. Serum levels of fractalkine, vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and vascular adhesion protein-1 (VAP-1) were elevated in patients with mild disease, dramatically elevated in severe cases, and decreased in the convalescence phase. We conclude the increased expression of endothelial cell adhesion molecules is related to COVID-19 disease severity and may contribute to coagulation dysfunction.
摘要
在一项对中国 39 例 COVID-19 患者和 32 例对照参与者的回顾性研究中，我们收集了临床数据，并通过酶联免疫吸附试验检测了内皮细胞黏附分子的表达。在轻症患者中，趋化因子 fractalkine、血管细胞黏附分子 1（VCAM-1）、细胞间黏附分子 1（ICAM-1）和血管黏附蛋白 1（VAP-1）的血清水平升高，在重症患者中显著升高，并在恢复期下降。我们得出结论，内皮细胞黏附分子的表达增加与 COVID-19 疾病的严重程度有关，可能导致凝血功能障碍。
相似文献
1
Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.血清内皮细胞黏附分子在 COVID-19 患者中的高表达。
J Infect Dis. 2020 Aug 17;222(6):894-898. doi: 10.1093/infdis/jiaa349.
2
Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.血清血管黏附蛋白-1与 2 型糖尿病患者的血管内皮生长因子相关。
J Diabetes Complications. 2013 Mar-Apr;27(2):162-6. doi: 10.1016/j.jdiacomp.2012.09.001. Epub 2012 Oct 11.
3
[Dealing with COVID-19-associated coagulopathy].[应对新型冠状病毒肺炎相关凝血病]
Ned Tijdschr Geneeskd. 2020 Apr 15;164:D5031.
4
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.严重 COVID-19 患者凝血功能障碍的表现及其与临床结局的关系：回顾性分析。
Int J Lab Hematol. 2020 Dec;42(6):766-772. doi: 10.1111/ijlh.13273. Epub 2020 Jun 27.
5
COVID-19 and coagulative axis: review of emerging aspects in a novel disease.新型冠状病毒肺炎与凝血轴：一种新型疾病的新进展综述
Monaldi Arch Chest Dis. 2020 May 19;90(2). doi: 10.4081/monaldi.2020.1300.
6
Coagulation Dysfunction.凝血功能障碍。
Arch Pathol Lab Med. 2020 Oct 1;144(10):1223-1229. doi: 10.5858/arpa.2020-0324-SA.
7
[Serum concentration of selected adhesive molecules in early localised and late disseminated Lyme borreliosis].[早期局限性和晚期播散性莱姆病中特定黏附分子的血清浓度]
Przegl Epidemiol. 2008;62(1):77-84.
8
[Coagulopathy and COVID-19. Recommendations for a changing reality].[凝血功能障碍与2019冠状病毒病。应对不断变化的现实的建议]
Medicina (B Aires). 2020;80(5):505-511.
9
Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).血小板功能和活性作为与 2019 年冠状病毒病（COVID-19）相关的潜在血液学参数。
Platelets. 2020 Jul 3;31(5):627-632. doi: 10.1080/09537104.2020.1762852. Epub 2020 May 13.
10
Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者凝血参数分析。
Biosci Trends. 2020 Sep 21;14(4):285-289. doi: 10.5582/bst.2020.03086. Epub 2020 Apr 30.
引用本文的文献
1
Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19.2019冠状病毒病糖尿病患者的血清可溶性细胞间黏附分子-1和半乳糖凝集素-3水平
Viruses. 2025 Jul 17;17(7):1005. doi: 10.3390/v17071005.
2
Fatty Acids and Inflammatory Protein Biomarkers From Coronavirus Disease 2019 Patients.2019冠状病毒病患者的脂肪酸和炎症蛋白生物标志物
Immun Inflamm Dis. 2025 Jul;13(7):e70218. doi: 10.1002/iid3.70218.
3
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与长期新冠——第1部分：刺突蛋白在长期新冠综合征病理生理机制中的影响
Viruses. 2025 Apr 25;17(5):617. doi: 10.3390/v17050617.
4
An analysis of novel endothelial biomarkers to ascertain their role as prognostic indicators in severe COVID-19 illness.分析新型内皮生物标志物，以确定它们在重症COVID-19疾病中作为预后指标的作用。
Indian J Med Res. 2025 Mar;161(3):298-305. doi: 10.25259/IJMR_915_2024.
5
Respiratory syncytial virus glycoprotein G impedes CXCR1-activation by CXCL1 and monocyte function.呼吸道合胞病毒糖蛋白G通过CXCL1阻碍CXCR1激活和单核细胞功能。
Npj Viruses. 2024 Dec 5;2(1):63. doi: 10.1038/s44298-024-00075-9.
6
Cardiovascular Symposium on Perspectives in Long COVID.长新冠视角下的心血管研讨会
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251319963. doi: 10.1177/10760296251319963.
7
Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin-angiotensin-aldosterone system inhibitors.内皮糖蛋白作为新冠病毒肺炎患者内皮炎症的标志物：静脉-静脉体外膜肺氧合、动脉高血压及既往肾素-血管紧张素-醛固酮系统抑制剂治疗对其的影响
Inflamm Res. 2025 Jan 25;74(1):26. doi: 10.1007/s00011-024-01964-8.
8
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.舒洛地昔治疗可下调康复期 COVID-19 患者内皮功能障碍的生物标志物。
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296241297647. doi: 10.1177/10760296241297647.
9
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.揭示严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白对新冠后综合征（PASC）神经系统长期影响的奥秘。
Front Cell Neurosci. 2024 Dec 18;18:1481963. doi: 10.3389/fncel.2024.1481963. eCollection 2024.
10
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白对人内皮细胞的持续血管炎症作用。
Inflammation. 2024 Dec 31. doi: 10.1007/s10753-024-02208-x.
本文引用的文献
1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
2
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
3
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
4
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.中国武汉 81 例新冠肺炎患者的放射学特征：一项描述性研究。
Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Vascular Endothelial Cell Biology: An Update.血管内皮细胞生物学：最新进展。
Int J Mol Sci. 2019 Sep 7;20(18):4411. doi: 10.3390/ijms20184411.
10
Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons.白细胞介素-1 通过对血管内皮细胞和胆碱能神经元的不同作用介导缺血性脑损伤。
Brain Behav Immun. 2019 Feb;76:126-138. doi: 10.1016/j.bbi.2018.11.012. Epub 2018 Nov 16.
Zotero 插件